# Rituximab in Recurrent IgA Nephropathy

> **NCT02571842** · PHASE4 · UNKNOWN · sponsor: **Chulalongkorn University** · enrollment: 30 (estimated)

## Conditions studied

- Recurrent IgA Nephropathy

## Interventions

- **DRUG:** Intravenous Rituximab
- **DRUG:** ACEI/ARB and corticosteroids

## Key facts

- **NCT ID:** NCT02571842
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02571842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02571842, "Rituximab in Recurrent IgA Nephropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02571842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*